Micropaque Scanner (Barium Sulfate)

Barium sulfate consists of insoluble particles with a high atomic number that strongly absorb X‑rays. When the suspension coats the lining of the gastrointestinal tract, it creates a dense, radiopaque layer that reflects X‑ray photons. The resulting contrast between the barium‑filled lumen and surrounding tissues allows clear visualization of the GI tract on radiographic images.

The dose of Micropaque Scanner is determined by the prescribing physician based on the specific imaging study, patient age, weight and clinical indication. The healthcare provider selects the appropriate volume and concentration of the suspension to achieve optimal radiographic contrast while considering safety and tolerability.

The safety of barium sulfate in pregnancy and lactation has not been definitively established. It is classified as a category unknown; therefore, it should be used only when the diagnostic benefit justifies any potential risk to the fetus or infant. Clinicians should discuss alternatives and weigh risks before administration.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any temperature‑controlled requirements) and assist with import documentation.

Barium sulfate provides high radiopacity for gastrointestinal imaging without systemic absorption, making it ideal for lumen studies. Iodine‑based agents are water‑soluble and used for vascular or soft‑tissue imaging, often administered intravenously. While iodine agents can be used for GI studies, they may cause more systemic reactions; barium offers superior coating of the GI mucosa but is contraindicated in suspected perforation or obstruction.

Micropaque Scanner should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly sealed, protect it from moisture, direct sunlight and extreme temperature fluctuations. Do not freeze the suspension. Before use, gently shake the bottle to ensure a uniform suspension, and inspect for any signs of contamination or separation.

The product is supplied as a liquid suspension that can be taken orally as a drink or introduced rectally via enema, depending on the imaging protocol. The administering clinician follows the specific procedural guidelines for the study, ensuring the patient ingests or receives the appropriate volume to coat the gastrointestinal tract adequately before imaging.

Serious risks include allergic reactions such as anaphylaxis, aspiration of barium into the lungs leading to respiratory distress, bowel obstruction or worsening of an existing blockage, gastrointestinal perforation, and severe electrolyte disturbances. Immediate medical attention is required if any of these events occur during or after the procedure.

Micropaque Scanner is contraindicated in patients with known hypersensitivity to barium sulfate, suspected or confirmed bowel obstruction, perforated gastrointestinal tract, severe dehydration, or those unable to tolerate oral/rectal administration. Caution is also advised for pregnant or breastfeeding women, and for individuals with significant renal impairment, where alternative imaging strategies may be preferable.